Coeo Labs with their indigenous medtech marvels, Saans and VAPCare

Forums Startups News (Startup) Coeo Labs with their indigenous medtech marvels, Saans and VAPCare

Tagged: 

  • This topic has 1 voice and 0 replies.
Viewing 0 reply threads
  • Author
    Posts
    • #34532
      TelegramGroup IoTForIndia
      Moderator
      • Topic 2519
      • Replies 0
      • posts 2519
        @iotforindiatggroup

        #News(Startup) [ via IoTForIndiaGroup ]


        When Nachiket and Nitesh did a deep dive into the problem, they found that ventilator associated pneumonia was a common global problem that needed to be addressed. In India alone, 6,00,000 patients get Ventilator Associated Pneumonia (VAP) each year, with the mortality associated with this condition as high as 40 percent.

        With respiratory distress syndrome (RDS) too, research showed that in India alone, more than 162,000 babies die every year, of which over 30 percent deaths occur due to the lack of infrastructure during transportation to tertiary care hospitals.

        CPAP, a technology recommended by the World Health Organisation, enables the provision of constant pressure and air flow to babies to prevent their alveoli, which is an important part of the respiratory system, from collapsing, thus ensuring their lungs remain open.
        This led Nachiket and Nitesh to participate in the medical hackathon organised by CAMtechIndia and GE Healthcare in 2014.
        And the foundation they sought to build their product on was simple: provide a breathing support system that does not have any dependency, whether it’s on physical infrastructure or on the availability of a trained clinical person. They were also clear that the breathing support or CPAP device they build should be gold standard quality, low cost, and be applicable for use across the globe.

        Today, Coeo Labs’ Saans, which in Hindi means “breath” or “air,” does refreshingly what the name itself suggests: give life to babies suffering from respiratory problems.

         

         

         


        Read More..

    Viewing 0 reply threads
    • You must be logged in to reply to this topic.